Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study.

Pathology international - 1 May 2013

Sakashita Naomi, Kagawa Seiko, Date Risako, Ueno Tatsuro, Nakagawa Takenobu, Yamashita Taro, Obayashi Konen, Ohshima Toshinori, Ueda Mitsuharu, Horiguchi Hidehisa, Ando Yukio, Takeya Motohiro

Abstract excerpt

Hepatocyte-derived mutant amyloidogenic transthyretin (ATTR) causes familial amyloidotic polyneuropathy (FAP), for which orthotopic liver transplantation is an established curative treatment. However, some patients with FAP have cardiac amyloidosis after transplantation. Here, we describe a man with an autonomic disorder diagnosed as FAP ATTR Val30Met and marked cardiomegaly after liver transplantation. He...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid
Share to Amyloid Neuropathies, Familial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Amyloidosis

Share to Autopsy

Share to Cardiomegaly

Share to Glucocorticoids

Share to Polyneuropathies

Share to Prednisolone

Source

Identifiers

PMID: 23714253
DOI: 10.1111/pin.12055

Genes

FAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study.PMID 23714253Read ↗

Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.Semantic proximity Read ↗

Familial amyloidotic polyneuropathy and transthyretin.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis caused by the rare Phe33Leu mutation.Semantic proximity Read ↗

Liver transplantation in transthyretin amyloidosis: issues and challenges.Semantic proximity Read ↗

Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.Semantic proximity Read ↗

Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.Semantic proximity Read ↗

Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.Semantic proximity Read ↗

Familial amyloidotic polyneuropathy (ATTR Ser50Ile): the first autopsy case report.Semantic proximity Read ↗

Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.Semantic proximity Read ↗

Transthyretin familial amyloidotic polyneuropathy: histopathological study of the explanted livers.Semantic proximity Read ↗

Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease.Semantic proximity Read ↗

Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.